In-patient smoking cessation tretment in comorbid patients with other substance dependance

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003344

Enrollment

200

Registered

2011-12-06

Start date

2011-03-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F17.2

Interventions

Group 1: smoking cessation therapy with combined psychotherapy and medication: Structured clinical interview and questionaires on admission, on day 7, at discharge and 3 months after discharge via a t

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: nicotine dependance, other substance dependance

Exclusion criteria

Exclusion criteria: severe cognitive deficitis

Design outcomes

Primary

Measure	Time frame
Nicotine abstinence rate 3 months after hospital discharge	—

Secondary

Measure	Time frame
1. Nikotine abstinence at discharge 2. nicotine reduction at discharge compared to admission 3. nicotine reduction 3 months after discharge compared to admission and discharge 4. other substance abstinence 3 months after discharge 5. rate of nicotine dependant patients who could be motivated to attempt smoking cessation during hospital stay. 6. nicotine reduction/abstinence 3 months after discharge: group comparison of varenicline arm, nicotine replacement therapy arm, Bupropione arm, only cognitive psychotherapy arm, no therapy arm 7. subgroup analysis of patient data for identification od patient subgroups profiting most from therapy program.	—

Measure

Time frame

1. Nikotine abstinence at discharge 2. nicotine reduction at discharge compared to admission 3. nicotine reduction 3 months after discharge compared to admission and discharge 4. other substance abstinence 3 months after discharge 5. rate of nicotine dependant patients who could be motivated to attempt smoking cessation during hospital stay. 6. nicotine reduction/abstinence 3 months after discharge: group comparison of varenicline arm, nicotine replacement therapy arm, Bupropione arm, only cognitive psychotherapy arm, no therapy arm 7. subgroup analysis of patient data for identification od patient subgroups profiting most from therapy program.

—

Countries

Germany

Contacts

Public ContactTillmann Weber

Zentralinstitut für Seelische Gesundheit Klinik für Abhängiges Verhalten und Suchtmedizin

tillmann.weber@zi-mannheim.de0621/17032235

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026